Status:
COMPLETED
Powered Assist to Improve Ambulation in Severe Lung Disease
Lead Sponsor:
West Park Healthcare Centre
Conditions:
Lung Disease Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic respiratory disease (CRD) is among the most prevalent and growing diseases worldwide with disabling consequences. Many with a compromised respiratory system cannot support the metabolic energy...
Eligibility Criteria
Inclusion
- stable chronic respiratory disease
- modified medical research council dyspnoea score (mMRC) ≥ 2
Exclusion
- evidence of cardiac rhythm or circulatory compromise
- myocardial infarct within the previous three months
- moderate-severe aortic stenosis
- uncontrolled hypertension
- sustained cardiac arrhythmias
- untreated neoplasia
- lung surgery within the previous three months
- any other predominant co-morbidities or treatments that might influence walk testing
- body size outside of exoskeleton fit specifications
- skin sores or skin breakdown in the area where the device is worn
- a high risk of fracture
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2021
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03790644
Start Date
August 1 2018
End Date
May 30 2021
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westpark Health Care Centre
Toronto, Ontario, Canada, M6M 2J5